The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $50.06

Today's change+0.10 +0.20%
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $50.06

Today's change+0.10 +0.20%
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.

Baxter International Inc Hits New 52-week High

Baxter International Inc closed up Wednesday by (U.S.)$0.10 or 0.20% to (U.S.)$50.06 and setting a new 52-week high. Over the last five days, shares have gained 1.25% and 12.90% year to date. Shares have outperformed the S&P 500 by 8.88% during the last year.

Key company metrics

  • Open(U.S.) $49.81
  • Previous close(U.S.) $49.96
  • High(U.S.) $50.22
  • Low(U.S.) $49.80
  • Bid / Ask-- / --
  • YTD % change+12.90%
  • Volume1,685,007
  • Average volume (10-day)2,185,630
  • Average volume (1-month)2,716,757
  • Average volume (3-month)3,620,109
  • 52-week range(U.S.) $37.69 to (U.S.) $50.22
  • Beta0.78
  • Trailing P/E5.57×
  • P/E 1 year forward23.17×
  • Forward PEG1.65×
  • Indicated annual dividend(U.S.) $0.52
  • Dividend yield1.04%
  • Trailing EPS(U.S.) $9.00
Updated February 22 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.58%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,6452,5582,5852,375
Total other revenue--------
Total revenue2,6452,5582,5852,375
Gross profit1,1021,037855965
Total cost of revenue1,5431,5211,7301,410
Total operating expense2,3632,3201,3695,329
Selling / general / administrative663611663620
Research & development157129150136
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--59-1,1743,163
Other operating expenses, total--------
Operating income2822381,216-2,954
Interest income (expense), net non-operating---20-16-33
Gain (loss) on sale of assets--------
Other--------
Income before tax2791281,2183,329
Income after tax2401271,2123,387
Income tax, total3916-58
Net income2431301,2123,380
Total adjustments to net income--------
Net income before extra. items2401271,2123,387
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2401271,2123,387
Inc. avail. to common incl. extra. items2431301,2123,380
Diluted net income2431301,2123,380
Dilution adjustment--------
Diluted weighted average shares549551553552
Diluted EPS excluding extraordinary itemsvalue per share0.440.232.196.14
Dividends per sharevalue per share0.130.130.130.12
Diluted normalized EPSvalue per share0.440.18-0.0411.67